Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action degraders |
Mechanism BRD7 degraders(Bromodomain-containing protein 7 degraders), BRD9 degraders(Bromodomain-containing protein 9 degraders), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC44H53N7O9S2 |
InChIKeyWPBRCJAGSVKMMS-UHFFFAOYSA-N |
CAS Registry2097509-20-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | 18 Apr 2017 |